| Name | Title | Contact Details |
|---|---|---|
Travis Thompson |
VP Managed Care and Network Strategy | Profile |
Jen Beck |
VP of Analytics | Profile |
Sunil Cardozo |
Chief Operations and Information Officer | Profile |
Pivot is a leading behavioral change digital health company aiming to engage employers and health plans who are eager to deliver elevated wellness solutions to individuals. Pivot Breathe, our flagship product, empowers millions to reduce and quit all forms of tobacco - and we`re just getting started.
Our goal is to advance knowledge and propose crosssectoral strategies and endeavours that will improve the health and well-being of Québecers. The Institut national de santé publique du Québec (INSPQ) was created in 1998 following the adoption of its act of incorporation (RSQ, chapter I-13.1.1). Its experts come from fields as distinct as applied science, health sciences, social sciences, and humanities and work with the health and social services network to develop and pool public health knowledge and skills.
BioAtla was founded in 2007 and employs deep expertise in protein engineering to develop better monoclonal antibody and other protein therapeutics. Our suite of proprietary technologies (protected by more than 70 issued patents and patent applications) has enabled us to develop dozens of novel therapeutic proteins for our partners and our own pipeline. We accelerate the process from target discovery to manufacturing and preclinical studies by creating drugs with more selective targeting, greater affinity, and more cost-efficient and predictable manufacturing. In the process we also create valuable, protectable IP that gives our partners significant competitive advantage. The culmination of our protein evolution technologies is our Conditionally Active Biologics (CAB)platform. Monoclonal antibodies or enzymes can be engineered for selective conditional activation, i.e. the protein`s functions are designed to modulate with changes in microphysical conditions (e.g., pH level, oxidation, temperature, pressure concentration, presence of certain ions, hydrophobicity and competing protein binding). Tumors and other kinds of diseased tissue give rise to unique localized conditions distinct from normal tissue. CAB designed monoclonal antibodies can be programmed to deliver an ADC payload and/or recruit the immune response to specific sites and conditions in the body.
Rehabilitation Network is a Youngstown, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Passport Health Northeast Pennsylvania is a Bethlehem, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.